Tandem Investment Advisors Inc. Raises Holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Tandem Investment Advisors Inc. raised its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 1.9% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 9,954 shares of the medical equipment provider’s stock after purchasing an additional 182 shares during the period. Tandem Investment Advisors Inc.’s holdings in Intuitive Surgical were worth $5,196,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other hedge funds and other institutional investors have also made changes to their positions in the stock. M.E. Allison & CO. Inc. purchased a new position in Intuitive Surgical in the fourth quarter worth approximately $449,000. Seilern Investment Management Ltd purchased a new stake in shares of Intuitive Surgical in the 4th quarter valued at approximately $82,517,000. Sycomore Asset Management raised its holdings in shares of Intuitive Surgical by 27.4% in the 4th quarter. Sycomore Asset Management now owns 18,945 shares of the medical equipment provider’s stock valued at $9,214,000 after purchasing an additional 4,079 shares in the last quarter. Exome Asset Management LLC lifted its position in shares of Intuitive Surgical by 16.8% during the 3rd quarter. Exome Asset Management LLC now owns 7,427 shares of the medical equipment provider’s stock worth $3,649,000 after purchasing an additional 1,069 shares during the last quarter. Finally, China Universal Asset Management Co. Ltd. grew its stake in shares of Intuitive Surgical by 5.6% during the fourth quarter. China Universal Asset Management Co. Ltd. now owns 9,843 shares of the medical equipment provider’s stock worth $5,138,000 after purchasing an additional 525 shares in the last quarter. Hedge funds and other institutional investors own 83.64% of the company’s stock.

Insiders Place Their Bets

In other Intuitive Surgical news, EVP Robert Desantis sold 376 shares of Intuitive Surgical stock in a transaction that occurred on Friday, November 29th. The stock was sold at an average price of $539.00, for a total value of $202,664.00. Following the sale, the executive vice president now owns 5,506 shares of the company’s stock, valued at approximately $2,967,734. The trade was a 6.39 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Amal M. Johnson sold 4,635 shares of the stock in a transaction that occurred on Tuesday, January 28th. The stock was sold at an average price of $566.60, for a total value of $2,626,191.00. Following the transaction, the director now directly owns 12,275 shares of the company’s stock, valued at approximately $6,955,015. This trade represents a 27.41 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last ninety days, insiders sold 6,348 shares of company stock valued at $3,587,582. 0.90% of the stock is owned by company insiders.

Wall Street Analysts Forecast Growth

A number of analysts have weighed in on the company. Stifel Nicolaus raised their price target on Intuitive Surgical from $525.00 to $610.00 and gave the company a “buy” rating in a research note on Thursday, December 5th. Barclays raised their target price on Intuitive Surgical from $610.00 to $674.00 in a research report on Monday, January 27th. Piper Sandler reaffirmed an “overweight” rating and issued a $670.00 price target (up from $538.00) on shares of Intuitive Surgical in a report on Friday, January 24th. BTIG Research raised their price objective on shares of Intuitive Surgical from $535.00 to $561.00 and gave the stock a “buy” rating in a report on Tuesday, November 26th. Finally, Jefferies Financial Group boosted their price objective on shares of Intuitive Surgical from $475.00 to $575.00 in a research report on Monday, January 27th. One analyst has rated the stock with a sell rating, five have issued a hold rating and sixteen have issued a buy rating to the company. According to MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $613.10.

Intuitive Surgical Stock Down 0.3 %

NASDAQ ISRG opened at $606.57 on Friday. The firm has a market cap of $216.05 billion, a P/E ratio of 94.63, a P/E/G ratio of 5.79 and a beta of 1.39. Intuitive Surgical, Inc. has a 52-week low of $364.17 and a 52-week high of $616.00. The business’s 50-day moving average price is $564.41 and its 200 day moving average price is $523.46.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.